We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...
Regulatory News: GeNeuro SA (Paris:GNRO) and GILBERT DUPONT have terminated the liquidity contract entered into on March 6, 2021. This termination took effect on June 30, 2024, after market...
Market: Euronext Paris ISIN code / Mnemo: CH0308403085 / GNRO Web site: www.geneuro.com Regulatory News: Pursuant to the liquidity contract entrusted by GENEURO SA (Paris:GNRO) to Gilbert Dupont...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 – GNRO): L'essai clinique GNC-501 est une étude de phase 2 chez des patients souffrant de syndromes neuropsychiatriques post-COVID-19...
81,54% du capital social de la société était représenté à l'assemblée générale et les résolutions ont toutes été approuvées à l’unanimité Regulatory News: GeNeuro (Euronext Paris : CH0308403085...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0024 | 3.44827586207 | 0.0696 | 0.0876 | 0.062 | 22555 | 0.07286382 | DE |
4 | -1.528 | -95.5 | 1.6 | 1.99 | 0.0558 | 114982 | 0.16494519 | DE |
12 | -1.128 | -94 | 1.2 | 2.35 | 0.0558 | 55836 | 0.34917108 | DE |
26 | -1.428 | -95.2 | 1.5 | 2.35 | 0.0558 | 31949 | 0.48806885 | DE |
52 | -3.778 | -98.1298701299 | 3.85 | 4.24 | 0.0558 | 13667 | 1.02118684 | DE |
156 | -3.788 | -98.1347150259 | 3.86 | 6.28 | 0.0558 | 10780 | 1.69683946 | DE |
260 | 0 | 0 | 0 | 0.078 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions